TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (Q3)Mar 31, 2021 | (FY)Dec 31, 2020 | (Q3)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -37.85%441.29M | -22.49%1.21B | -18.73%709.99M | -15.05%1.56B | 0.64%873.61M | 124.42%1.84B | --868.08M | 494.11%368.57M | 44.82%817.95M | --62.04M |
Operating income | -37.85%441.29M | -22.49%1.21B | -18.73%709.99M | -15.05%1.56B | 0.64%873.61M | 124.42%1.84B | 868.08M | 494.11%368.57M | 44.82%817.95M | 62.04M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Selling expenses | -91.65%-8.13M | 42.76%-19.68M | 74.43%-4.24M | 19.10%-34.38M | 0.66%-16.59M | -176.01%-42.5M | ---16.7M | -421.53%-6.01M | -27.75%-15.4M | ---1.15M |
Employee expense | 43.06%-96.53M | 70.22%-298.8M | 55.38%-169.53M | -72.53%-1B | -22.16%-379.95M | -225.06%-581.63M | ---311.03M | -845.97%-190.36M | -93.92%-178.93M | ---20.12M |
Depreciation and amortization | 46.55%-63.91M | 61.32%-199.58M | 49.88%-119.58M | -70.35%-515.94M | -120.44%-238.58M | -120.57%-302.86M | ---108.23M | -78.17%-50.03M | -94.46%-137.31M | ---28.08M |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---207.67M | --11.35M | ---- | ---- | ---- |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---207.67M | --11.35M | ---- | ---- | ---- |
Impairment and provision | ---414K | 98.38%-11.58M | ---- | -6,389.80%-712.91M | ---47.17M | ---10.99M | ---- | ---- | ---- | ---- |
-Impairment of property, machinery and equipment | ---- | 98.41%-11.34M | ---- | -6,389.80%-712.91M | ---47.17M | ---10.99M | ---- | ---- | ---- | ---- |
-Other impairment is provision | ---414K | ---241K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | 26.60%-226.53M | 34.89%-567.81M | 35.67%-308.61M | -7.70%-872.05M | -16.36%-479.76M | -124.47%-809.69M | ---412.31M | -545.42%-175.69M | -34.30%-360.72M | ---27.22M |
Operating profit | -57.63%45.77M | 107.04%111.17M | 137.45%108.03M | -1,219.23%-1.58B | -1,025.44%-288.43M | -195.33%-119.72M | 31.17M | -268.12%-53.52M | 3.55%125.59M | -14.54M |
Financing income | -28.98%29.8M | 1,283.02%68.6M | 4,624.55%41.95M | 780.99%4.96M | 3,315.38%888K | 1,555.88%563K | --26K | 71.43%12K | 142.86%34K | --7K |
Financing cost | 64.94%-6.11M | 33.82%-27.8M | 53.02%-17.43M | 27.18%-42.01M | -41.59%-37.1M | -101.30%-57.69M | ---26.21M | -77.03%-11.82M | -74.98%-28.66M | ---6.68M |
Earning before tax | -47.60%69.46M | 109.40%151.96M | 140.83%132.55M | -814.04%-1.62B | -6,609.91%-324.65M | -282.38%-176.85M | 4.99M | -208.04%-65.32M | -7.58%96.97M | -21.21M |
Tax | -99.13%218K | 86.24%28.54M | 21.62%24.94M | 128.83%15.32M | 168.76%20.51M | -97.62%-53.15M | ---29.82M | -337.44%-11.01M | -4.32%-26.9M | --4.64M |
After-tax profit from continuing operations | -55.76%69.68M | 111.27%180.5M | 151.78%157.49M | -596.15%-1.6B | -1,124.61%-304.14M | -428.23%-230M | -24.84M | -360.69%-76.33M | -11.45%70.07M | -16.57M |
Earning after tax | -55.76%69.68M | 111.27%180.5M | 151.78%157.49M | -596.15%-1.6B | -1,124.61%-304.14M | -428.23%-230M | -24.84M | -360.69%-76.33M | -11.45%70.07M | -16.57M |
Profit attributable to shareholders | -55.76%69.68M | 111.27%180.5M | 151.78%157.49M | -596.15%-1.6B | -1,124.61%-304.14M | -428.23%-230M | -24.84M | -360.69%-76.33M | -11.45%70.07M | -16.57M |
Basic earnings per share | -55.65%0.055 | 109.73%0.142 | 149.80%0.124 | -584.98%-1.459 | -896.00%-0.249 | -404.29%-0.213 | -0.025 | -347.06%-0.076 | -11.39%0.07 | -0.017 |
Diluted earnings per share | -55.65%0.055 | 109.73%0.142 | 149.80%0.124 | -584.98%-1.459 | -896.00%-0.249 | -413.24%-0.213 | -0.025 | -347.06%-0.076 | -11.69%0.068 | -0.017 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | Unqualified Opinion | -- |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.